Press release
Immunoassay Interference Blocker Market 2022 Global Projection By Key Players - Abcam plc, AMS Biotechnology (Europe) Limited, Aviva Systems Biology Corporation- Analysis and Forecast to 2031
Immunoassay Interference Blocker Market 2022-2031
The Immunoassay Interference Blocker Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients' lives. This convenience quotient would be the trend running in the healthcare vertical shortly.
As per Persistence Market Research's latest revised industry analysis, the global immunoassay interference blocker market was valued at US$ 223 Mn in 2020, and is expected to exhibit a CAGR of 6.7% over the forecast period (2022-2031).
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/24343
Substances that modify quantifiable concentration of analytes or change antibody binding can conceivably result in immunoassay interference. Prevalence of interference is usually less in assays holding blocking agents, which counteract or inhibit the interference. Detection of interference may involve usage of a different assay, or quantification before and after treatment with supplementary blocking reagents.
Growing prevalence of chronic diseases and increasing aging population across the world are factors that are expected to surge the need for biochemical testing for the management of chronic diseases. Increase in aging population is likely to escalate demand for diagnostic kits and reagents for the detection of age-related as well as other chronic conditions. This is expected to drive the immunoassay interference blocker market over the forecast period of 2021 to 2031.
Governments around the world are supporting the growth of specialty medical diagnostic reagents, which further drives research & development. Immunoassay interference blocker kits and reagents play a vital role in preventing unnecessary interference generated while preforming an immunoassay-based disease detection test. Hence, an increase in growth of immunoassay interference blockers has been witnessed due to rising government support and funding.
Key manufacturers of immunoassay interference blockers have been focusing on expansion and new product launch programs to increase their consumer base in different geographies.
In 2019, Bio Rab Laboratories announced the launch of an innovative test to aid in the diagnosis of Lyme disease, with the FDA clearance of the bioplex 2200 Lyme total assay.
In 2021, Thermofisher Scientific planned for its manufacturing site expansion in the region of Mebane, N.C. USA.
Company Profiles:
Abcam plc
AMS BioApplication (Europe) Limited
Aviva Systems Biology Corporation
Bio-Rad Laboratories, Inc.
Meridian Bioscience, Inc.
Roche Diagnostics GmbH
Rockland Immunochemicals, Inc.
Scantibodies Laboratory, Inc.
Thermo Fisher Scientific
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/24343
Key Takeaways from Market Study
Antibody interference blockers hold the largest market share as compared to other products, expanding at a CAGR of 6.4%. A similar trend is expected to continue, primarily due to their high efficiency and reliable assay outcomes.
The application segment is led by antibody capture assays with a share of 39.8% in 2020, owing to high, precise, and accurate results with least interference obtained via immunoassay interference blockers.
Academic and research institutes dominated the end user segment with a share of around 39.5% in 2020. This segment is expected to grow two-fold by the end of 2031 due to increasing usage of immunoassay interference blockers in research activities to introduce novel applications.
By region, North America is slated to be the largest regional market with a value share of 33.3% at the end of the forecast period, due to constant clinical efforts to establish advanced diagnostics biologics and new drug discovery in the region.
"Increasing healthcare R&D spending and government support, continual technological advancements, and growing demand for better diagnosis are boosting demand for immunoassay interference blockers," says an analyst of Persistence Market Research.
Impact of Market Consolidation
Considering consolidation activities in the global market, strategic focus on novel product development and research based on advanced immunoassay interference blockers are some of the key growth strategies by market players. Prominent players are strengthening their product ranges through acquisitions and reaching out to key as well as emerging markets.
For instance:
In April 2020, Bio Rad Laboratories, Inc. announced the commercial launch of its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.
The research study is based on the product (antibody interference blockers, detection interference blockers, and surface interference blockers), application (sandwich immunoassays, antibody capture assays, competitive ELISA, and others) and end user (biotechnology companies, contract research organizations, academic and research institutes, and molecular diagnostics companies), across seven key regions of the world.
Major Highlights of the Immunoassay Interference Blocker Market Report:
The Immunoassay Interference Blocker Market analysis report offers an in-depth study of the potential market growth opportunities and challenges.
The report dives deeper into the market and explains the dynamic factors bolstering market growth.
The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.
The report analyzes the Immunoassay Interference Blocker Market presence across major regions of the world.
It determines the production & consumption capacities and demand & supply dynamics of each regional market.
The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.
It provides company overview and SWOT analysis of each of the market players.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/24343
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About PersistenceMarketResearch:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against reputed organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoassay Interference Blocker Market 2022 Global Projection By Key Players - Abcam plc, AMS Biotechnology (Europe) Limited, Aviva Systems Biology Corporation- Analysis and Forecast to 2031 here
News-ID: 2587650 • Views: …
More Releases from Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Immunoassay
Prominent Chemiluminescence Immunoassay Analyzer Market Trend for 2025: Innovati …
What combination of drivers is leading to accelerated growth in the chemiluminescence immunoassay analyzer market?
The increasing incidence of chronic illnesses is predicted to spur the expansion of the chemiluminescence immunoassay analyzer market. Factors like aging populations, unhealthy lifestyles, and advancements in healthcare which prolong the lifespan of individuals with severe conditions, contribute to the rise in chronic diseases. Chemiluminescence immunoassay analyzers play a crucial role in managing chronic illnesses by…
Global Bench-top Automated Immunoassay Analyzer Market Size - By Product Type(Ch …
Bench-top Automated Immunoassay Analyzer Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Bench-top Automated Immunoassay Analyzer Market Scope: Unveiling Today's Trends
A Bench-top Automated Immunoassay Analyzer is a compact device used for conducting immunoassays in laboratory settings, enhancing efficiency and accuracy. The market for these analyzers is experiencing significant growth driven by rising demand for rapid diagnostic testing and advancements in technology. Increased prevalence of conditions such as infectious diseases and…
Immunoassay Market - Advancing Patient Care through Immunoassay Solutions
Newark, New Castle, USA: The "Immunoassay Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Immunoassay Market: https://www.growthplusreports.com/report/immunoassay-market/8429
This latest report researches the industry structure, sales, revenue, price and…
Bahrain Immunoassay Analyzer Market
Transparent healthcare framework & strict procurement system enables the authorities in gaining the trust of the end-users leading to the growth of the medical devices industry in Bahrain: Ken Research
Heavy Government involvement in the industry: Bahrain has been maintaining a basic framework for a transparent, rules-based government procurement system. Bahrain hospitals and clinics, as well as developing specialist treatments, are continuously growing. This has improved the installation of BGA, POC…
Immunoassay Market Competitive Dynamics 2027
According to the new research report published by The Insight Partners, titled "Immunoassay Market- Global Analysis and Forecast to 2027".
The global immunoassay market is US$ 21,800.0 Mn in 2018 and is predicted to grow at a CAGR of 6.5% during the forecast period 2019 - 2027, to reach US$ 37,987.8 Mn by 2027.
Immunoassay Market Report presents a competitive scenario of key Immunoassay Industry players with their market share, sales, revenue…
Immunoassay Market: Opportunities and Challenges
The Immunoassay Market is expected to reach 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436
Will the development of condition-specific biomarkers and tests create opportunities for growth for players in the immunoassay market?
Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases.…
